Introduction {#s01}
============

Organisms must coordinate growth with the nutritional status of their environment to maintain tissue homeostasis. Multiple intrinsic and extrinsic signals are integrated by cells to control body size ([@bib40]; [@bib30]). The highly conserved insulin/insulin-like growth factor (IGF) signaling pathway plays a key role in controlling systemic growth and in various aspects of organismal physiology, including longevity, stress resistance, and fecundity (in both vertebrates and invertebrates; [@bib5]; [@bib40]; [@bib23]; [@bib30]; [@bib32]).

In *Drosophila melanogaster*, eight insulin-like peptides (ILP1--8), which are homologous to vertebrate insulin/IGF, have been identified. These genes are expressed in distinct spatial and temporal patterns ([@bib39]; [@bib23]; [@bib11]). Studies using flies as a model have led to significant insights regarding the roles of ILPs as determinants of systemic growth ([@bib5]; [@bib45]). Unlike mammalian insulin, which is secreted from the pancreas, the major fly ILPs (ILP2, ILP3, and ILP5) are specifically expressed in clusters of neurosecretory neurons and insulin-producing cells (IPCs) in the anteromedial region of the brain and are secreted into the hemolymph from IPC axon terminals ([@bib28]; [@bib1]). The secretion of ILP from IPCs in the brain is tightly controlled by nutrient availability, thereby linking systemic growth with environmental conditions ([@bib36]; [@bib21]; [@bib44]). In this way, the synthesis and secretion of ILPs by IPCs play a central role in controlling the systemic growth rate ([@bib21]; [@bib24]; [@bib1]). However, little is known about the mechanisms that control the biogenesis and release of ILPs by IPCs.

Circulating insulin/IGF regulates cell growth by activating the evolutionarily conserved insulin/mechanistic target of rapamycin complex 1 (mTORC1) pathway in somatic cells ([@bib40]; [@bib30]; [@bib31]). The tuberous sclerosis complex (TSC), which consists of TSC1 and TSC2, is an essential node of the insulin/mTORC1 pathway ([@bib38]). mTORC1 promotes cell growth in response to both nutrients and insulin/IGF, and the TSC negatively regulates mTORC1 by functioning as a GTPase-activating protein for Rheb, an essential activator of mTORC1 ([@bib29]; [@bib47]; [@bib48]; [@bib56]). Insulin/IGF activates mTORC1 signaling by inhibiting the TSC through the insulin receptor/phosphoinositide 3-kinase/AKT signaling cascade ([@bib13]). A TBC1 Domain Family Member 7 (TBC1D7) was recently identified as the third core subunit of the TSC ([@bib14]). TBC1D7 stabilizes the TSC through direct interactions with TSC1, thus TBC1D7 knockdown decreased GTPase-activating protein activity of TSC toward Rheb, which limits mTORC1 signaling and cell growth ([@bib14]; [@bib18]; [@bib43]). Somatic loss of heterozygosity in TSC1 or TSC2 leads to the occurrence of benign tumors in various organs ([@bib15]; [@bib50]). However, loss of TBC1D7 is associated with intellectual disability and megalencephaly ([@bib10]; [@bib2]). These divergent phenotypes imply that TBC1D7 has important physiological functions that are distinct from its TSC complex--associated functions. Nevertheless, the physiological roles of TBC1D7 have not been well studied.

Results and discussion {#s02}
======================

With the goal of dissecting the physiological functions of TBC1D7, we identified *CG6182* as the only gene with homology to *TBC1D7* in the fly genome. Identical and conserved residues were 32.5% and 52.2%, respectively, when CG6182 and human TBC1D7 protein sequences were aligned (through BLASTP \[<http://flybase.org/blast/>\] analysis of human TBC1D7 and fly genomes; Fig. S1 A). Consistent with previous work, overexpressing TSC1 and TSC2 simultaneously in the compound eye of *Drosophila* resulted in smaller ommatidia (compared with control eyes), through down-regulation of mTORC1 (Fig. S1, B--D; [@bib19]; [@bib42]; [@bib20]). However, when levels of dTBC1D7 were manipulated (either overexpressed or knocked down) in combination with TSC1 and TSC2 overexpression, the size of the ommatidia was not affected (Fig. S1, B--D). With these interesting results, we generated a null *dTBC1D7* mutant (*dTBC1D7^KO^*) using CRISPR/Cas9-mediated genome editing (Fig. S1, E and F). Whereas *TSC1* and *TSC2* homozygous mutants are lethal, homozygous *dTBC1D7* mutants were viable. These results suggest that TBC1D7 may not be a constitutive component of the TSC.

We found that *dTBC1D7^KO^* flies exhibited larger body sizes than wild-type flies at both the pupal and adult stages ([Fig. 1, A and B](#fig1){ref-type="fig"}). Mutant flies had significantly higher body weights (22%, P \< 0.001) than wild-type flies regardless of sex (male flies were chosen for further investigation; [Fig. 1 C](#fig1){ref-type="fig"}). To determine whether this increase in size and weight resulted from the enlargement of particular organs or tissues, we assessed growth of the eye and wing, because growth of these tissues has been extensively characterized. Compared with wild-type flies, *dTBC1D7^KO^* flies exhibited (1) larger ommatidia, but the number of ommatidia did not differ ([Fig. 1, D--F](#fig1){ref-type="fig"}), and (2) larger average wing areas with the number of cells remaining the same ([Fig. 1, G--I](#fig1){ref-type="fig"}). Furthermore, whole-body overgrowth was rescued by the ubiquitous expression of a *UAS-dTBC1D7* transgene by the *daughterless-Gal4* (*da-Gal4*) driver ([Fig. 1 J](#fig1){ref-type="fig"}). These results indicate that dTBC1D7 is involved in regulating multiple growth processes in *Drosophila*.

![***dTBC1D7* mutant increased body size. (A and B)** The overgrowth of the dTBC1D7KO animals was found in both pupa (A) and adult stages (B). Bars, 400 µm. **(C)** Quantification of body weight of 3-d-old flies. At least 200 flies were used for each genotype. **(D)** Scanning electron microscopy of wild-type, *dTBC1D7*, mutant, *FRT 82B* (*ey-flpRh1::GFP;;FRT82B/GMR-hid CL FRT82B*), and *FRT82B dTBC1D7 ^KO^/FRT82B GMR-hid* (*ey-flpRh1::GFP;;FRT82B, dTBC1D7^KO^/FRT82B, GMR-hid CL*) compound eyes. Bars, 100 µm. **(E)** Quantification of ommatidia size. At least 20 male flies of each genotype were assayed. **(F)** The total number of ommatidia in rows 14--18 of compound eyes was counted. At least 20 male flies of each genotype were assayed. **(G)** The wings of wild-type and *dTBC1D7* mutant flies. Bars, 200 µm. **(H and I)** Qualification of wing area (H) and cell number (I) of *dTBC1D7* mutants and wild-type. Wings from at least 20 male flies of each genotype were measured. **(J)** Ubiquitous expression of dTBC1D7 (*da\>dTBC1D7: da-Gal4/UAS-dTBC1D7*) rescued the increased body weight of *dTBC1D7* mutants (KO: dTBC1D7KO). At least 200 male or female flies of each genotype were used. Error bars indicate the SD, and significant differences against same-sex wild-type flies were determined with Student's *t* test at indicated genotypes. \*\*\*, P \< 0.001; ns, not significant.](JCB_201706027_Fig1){#fig1}

It is known that up-regulation of mTORC1 activity results in cell-autonomous overgrowth in *Drosophila* ([@bib47]; [@bib48]; [@bib51]). We surmised that the overgrowth of *dTBC1D7* mutants may result from the up-regulation of mTORC1 kinase activity, because TBC1D7 has been identified as the third subunit of the TSC ([@bib14]). To test this hypothesis, we first measured the phosphorylation status of a major mTORC1 substrate, the P70 ribosomal protein S6 kinase (S6K), which is thought to be indicative of mTORC1 kinase activity. Knockdown of TSC1 and/or TSC2 in S2 cells increased pS6K levels ([Fig. 2 A](#fig2){ref-type="fig"}). Conversely, pS6K levels were unchanged in both *dTBC1D7* knockdown cells and *dTBC1D7^KO^* flies, suggesting that the mTORC1 kinase activity was not affected in *dTBC1D7* mutant cells ([Fig. 2, B--C](#fig2){ref-type="fig"}). Collectively, these data indicate that dTBC1D7 may not be essential for TSC activity.

![***dTBC1D7* regulated growth in a cell-nonautonomous manner. (A)** Knockdown of *TSC1*, *TSC2*, or *TSC1* and *TSC2*, but not *dTBC1D7*, in S2 cells by RNAi increased the phosphorylation levels of S6K (pS6K). *DsRNA* for GFP was used as a negative control. The efficiency of *TBC1D7* knockdown in S2 cells was ∼60%, as determined by qPCR. S6K mRNA levels were not changed among the groups. **(B)** Western blot of pS6K in the wild-type and *dTBC1D7* mutant flies. S6K mRNA levels were not changed among the groups. **(C)** Quantification of relative pS6K levels from three biological replicates from panel B. **(D--E)** Cells mutant for *dTBC1D7* were the same sizes as the neighbor cells. **(D)** Clones of homozygous *dTBC1D7^KO^* cells marked with GFP were generated in fat body by the MARCM system, and cell boundaries were stained with phalloidin. Bar, 50 µm. **(E)** Quantification of the *dTBC1D7^KO^* and neighbor cells. At least 100 clones in six individuals were measured. **(F--G)** Overexpression of *dTBC1D7* did not affect cell growth. **(F)** The *dTBC1D7* overexpression (+dTBC1D7) clones were marked with GFP. Bar, 50 µm. **(G)** The cell size quantification of +dTBC1D7 clones. At least 100 clones in six individuals were measured. Bars, 50 µm. Error bars indicate SD, and significant differences were determined with Student's *t* test at indicated genotypes. **(H)** The *dTBC1D7^KO^* fat body cells showed membrane localization of GPH. Bar, 50 µm. **(I)** Levels of pAKT and pS6K in fat body of wild-type, *ilp2^1^*, and *dTBC1D7^KO^* flies as assessed by using Western blot analysis. ns, not significant.](JCB_201706027_Fig2){#fig2}

We then asked whether TBC1D7 regulates growth in a cell-autonomous or nonautonomous manner. To answer this question, we first used a modified mitotic recombination approach to kill nonrecombinant retina cells by the eye-specific expression of the proapoptotic gene, *hid*. This generated homozygous *dTBC1D7^KO^* mutant eyes in otherwise heterozygous animals (*FRT82B dTBC1D7^KO^/FRT82B GMR-hid*; [@bib53]). In contrast with whole-animal mutant *dTBC1D7^KO^* flies, which exhibit an increase in ommatidia size, compound eyes of *FRT82B dTBC1D7^KO^/FRT82B GMR-hid* flies had ommatidia of normal size ([Fig. 1, D--F](#fig1){ref-type="fig"}). Furthermore, homozygous *dTBC1D7^KO^* clones of cells were generated with the mosaic analysis with a repressible cell marker (MARCM) system ([@bib35]), and clones of cells overexpressing *dTBC1D7* were generated with the "flip out" method ([@bib49]). Thus, both dTBC1D7 loss- and gain-of-function cells were marked with GFP. When the fat body was subjected to phalloidin staining, boundaries between these clones and control cells were clearly visible. Cells lacking *dTBC1D7* ([Fig. 2, D and E](#fig2){ref-type="fig"}) or overexpressing *dTBC1D7* ([Fig. 2, F and G](#fig2){ref-type="fig"}) were both the same size as surrounding control cells, regardless of nutrition status. Collectively, these data indicate that dTBC1D7 may not be essential for TSC activity and that loss of *dTBC1D7* induces growth in a cell-nonautonomous manner.

Growth also would be regulated by the circulating insulins. We next examined whether the increased circulating insulins in *dTBC1D7* mutant flies activate the insulin signal transduction pathway by using the tGPH indicator, which fuses the PH domain of the *Drosophila* homologue of the general receptor for phosphoinositides-1 (GRP1) to GFP and reflects activation of cellular insulin signal transduction pathway ([@bib4]; [@bib40]; [@bib47]). Similar to previous studies, under starvation conditions GPH localized to the cytoplasm and nucleus of fat body cells, indicating a limited amount of insulin secretion ([Fig. 2 H](#fig2){ref-type="fig"}). However, under the same condition, GPH instead localized to the plasma membrane of *dTBC1D7* mutant cells ([Fig. 2 H](#fig2){ref-type="fig"}). To confirm that systemic insulin signaling activity is increased in *dTBC1D7^KO^* flies, we examined the activity of AKT and TORC1, which are downstream effectors of insulin signaling, in fat body. Mutation of *dTBC1D7* promoted phosphorylation of Akt on Ser505 under starvation conditions, suggesting high levels of systemic insulin signaling in *dTBC1D7^KO^* animals ([Fig. 2 I](#fig2){ref-type="fig"}). However, TORC1-dependent phosphorylation of S6K Thr398 did not increase. Similarly, levels of pAKT, but not pS6K, were reduced in *ilp2* mutant fat bodies, which is consistent with previous studies in which *ilp2* mutants showed normal TORC1 activation in fat body ([Fig. 2 I](#fig2){ref-type="fig"}; [@bib31]). This differential effect on TORC1 activation may be because mTORC1 is primarily regulated by intracellular nutrients.

It has been established that extracellular signals, such as ILPs secreted by IPCs in *Drosophila*, control systemic growth in cell nonautonomous ways ([@bib5]; [@bib28]; [@bib45]; [@bib12]; [@bib32]). Previous work has revealed that the *Drosophila* genome encodes eight ILPs (ILP1--8) and that these ILPs are synthesized and secreted in different tissues at different developmental stages to regulate growth and development ([@bib39]; Colombani et al., 2012). Thus, we measured levels of transcription for all *ilp* genes in *dTBC1D7* mutants using quantitative PCR (qPCR). Interestingly, we found that *ilp2* mRNA levels were significantly up-regulated in *dTBC1D7* mutants compared with wild-type controls, in both larvae and adult flies (2.5- and 1.5-fold, respectively) ([Fig. 3, A and B](#fig3){ref-type="fig"}). Many studies have shown that the synthesis and secretion of ILP2 by IPC neurons is the key regulator of growth in flies ([@bib28]; [@bib45]; [@bib23]; [@bib32]). We therefore used immunostaining to detect ILP2 in IPC neurons that were marked with GFP (*Ilp2-Gal4*/*UAS-GFP*) and found that in wild-type flies ILP2 appeared in a granule-like pattern, very similar to patterns reported for human IPCs ([@bib41]). In contrast, ILP2 granules were almost undetectable in *dTBC1D7* mutants ([Fig. 3 C](#fig3){ref-type="fig"}). Thus, increased levels of ILP2 production and secretion by IPC neurons may underlie the increased growth observed in *dTBC1D7* mutants.

![**Secretion of ILP2 was elevated in the *dTBC1D7* mutant flies. (A--B)** Transcriptional levels of *ilps* in the wild-type and *dTBC1D7* mutant animals at (A) larval stage and (B) adult stage were measured by qPCR. The expression of *ilp6* was not detected in adult animals. Five independent replicates were used for quantification. **(C)** Brain staining of ILP2 in the wild-type and *dTBC1D7^KO^* flies with GFP expression in ILP2 cells (*Ilp2\>GFP*: *Ilp2-Gal4/UAS-GFP*). Flies were dissected and immunostained for GFP (green) and ILP2 (red). High magnification pictures are shown in yellow frames. Bar, 50 µm. **(D)** Measurement of circulatory ILP2 in the hemolymph in the wild-type and *dTBC1D7^KO^* and *ilp2^1^* flies. The top PAGE gels were stained with Coomassie brilliant blue, and one 100-kd band of putative larval serum protein was used as loading control. The bottom PAGE gels were used for Western blot against ILP2. **(E)** Quantification of circulatory ILP2 from five biological replicates based on panel D. **(F)** Determination of circulatory glucose in hemolymph of the wild-type and *dTBC1D7* mutant flies. Six biological replications were used for qualification. Error bars indicate SD. Significant differences were determined with Student's *t* test at indicated genotypes. \*\*\*, P \< 0.001; ns, not significant.](JCB_201706027_Fig3){#fig3}

Furthermore, we directly measured levels of circulating ILP2 in hemolymph from wild-type, *dTBC1D7^KO^*, *and ilp2* mutant flies by Western blot. The ILP2 Western blot analysis revealed that levels of circulating ILP2 were increased in *dTBC1D7* mutant flies ([Fig. 3, D and E](#fig3){ref-type="fig"}). Insulins are well known to control circulating glucose levels in various organisms ([@bib32]). Indeed, the concentration of glucose in the hemolymph of *dTBC1D7^KO^* animals was significantly lower than in wild-type animals ([Fig. 3 F](#fig3){ref-type="fig"}). Collectively, our data establish that circulating insulin was elevated in *dTBC1D7* mutants.

To determine how dTBC1D7 regulates the synthesis and release of ILP2, we first characterized the expression pattern of *dTBC1D7* in flies. Using CRISPR/Cas9 genome editing, we generated an mCherry knock-in allele, in which mCherry expression is driven by the native *dTBC1D7* promoter (*dTBC1D7-mCherry*; Fig. S2, A--C). mCherry Western blotting first revealed that *dTBC1D7* expression was specifically enriched in the brain and ovaries (Fig. S2 D). Staining brains from larvae and adults with antibodies against mCherry and ILP2 showed that mCherry primarily localized to a subset of neurons that almost all contained ILP2 ([Fig. 4, A and B](#fig4){ref-type="fig"}). This suggests that *dTBC1D7* is expressed in and may function in the IPC neurons. Encouragingly, expression of *dTBC1D7* in (1) IPC neurons (*Ilp2-Gal4*/*UAS-dTBC1D7*), (2) all neurons (*elav-Gal4*/*UAS-dTBC1D7*), or (3) whole flies (*da-Gal4/UAS-dTBC1D7*) rescued the systemic overgrowth of *dTBC1D7^KO^* mutants. In contrast, expressing *dTBC1D7* in muscle (*Mhc-gla4*/*UAS-dTBC1D7*) did not rescue the *dTBC1D7^KO^* overgrowth phenotypes ([Fig. 4, C--E](#fig4){ref-type="fig"}). Similar to *dTBC1D7* mutant animals, tissue-specific overexpression of ILP2 in IPC neurons resulted in increased body weight, and expression of an d*TBC1D7* RNAi transgene in IPC neurons resulted in increased body weight and lower levels of circulating glucose ([Fig. 4, F and G](#fig4){ref-type="fig"}). It is worth mentioning that direct overexpression of ILP2 had less effect on body weight than *dTBC1D7* knockdown, which may be because the secretion of ILP2 is regulated ([@bib9]). IPC-specific knockdown of *dTBC1D7* in IPC neurons did not fully recapitulate the *dTBC1D7^KO^* phenotypes, which might imply that other dTBC1D7-expressing cells contribute to systemic growth regulation as well. Importantly, the overgrowth phenotypes of *dTBC1D7* mutants (including body weight, ommatidia size, and wing area) were completely reversed by introducing the *ilp2* mutation ([Fig. 4, H--J](#fig4){ref-type="fig"}). Furthermore, membrane localization of the GPH signaling after starvation treatment could be rescued by IPC-specific expression of *dTBC1D7* ([Fig. 4 K](#fig4){ref-type="fig"}). The epistasis analysis between *dTBC1D7* and *ilp2* indicated that the induction of growth in *dTBC1D7* mutants required ILP2. These results suggest that TBC1D7 functions in IPC neurons and that this IPC-neuron--specific function is sufficient to control growth.

![***dTBC1D7* expressed and functioned in IPC neurons. (A)** Staining of mCherry and ILP2 in the brain of *dTBC1D7* knock-in larvae (*dTBC1D7-mCherry*), in which mCherry expression was driven by the native promoter of *dTBC1D7*. **(B)** Staining of mCherry and ILP2 in the brain of *dTBC1D7-mCherry* flies at the adult stage. Bars: (top) 50 µm; (bottom) 100 µm. **(C--E)** Rescue of the overgrowth phenotypes of *dTBC1D7* mutant by expression of dTBC1D7 in all cells (*da\>dTBC1D7: da-Gal4/UAS-dTBC1D7*), neuronal cells (*elav\>dTBC1D7: elav-Gal4/UAS-dTBC1D7*), and IPC neurons (*Ilp2\>dTBC1D7: Ilp2-Gal4/UAS-dTBC1D7*); muscle expression (*Mhc\>dTBC1D7: Mhc-Gal4/UAS-dTBC1D7*) failed to rescue the growth phenotypes. Body weight (C), ommatidia size (D), and wing area (E) were quantified. The "control" refers to the *Ilp2-Gal4*/+ flies. **(F)** Knockdown *dTBC1D7* (*Ilp2\>dTBC1D7RNAi: Ilp2-Gal4/UAS-dTBC1D7RNAI*) or overexpression of *ilp2* in IPC neurons (*Ilp2\>ilp2: Ilp2-Gal4/UAS-ilp2*) increased body sizes. At least 200 male flies of each genotype were used. The "control" refers to the *Ilp2-Gal4/+* flies. Levels of *dTBC1D7* transcripts in the *Ilp2\>dTBC1D7RNAi* brain were reduced 50% compared with control brains. **(G)** Circulatory glucose levels decreased in hemolymph of the *Ilp2\>dTBC1D7RNAi* flies. Five biological replications were used for quantification. **(H--J)** Mutation of *ilp2* (*ilp2^1^*) rescued growth phenotypes, included body weight (H), ommatidia size (I), and relative wing area (J) of *dTBC1D7^KO^* animals. At least 20 male flies of each genotype were assayed. Significant differences were determined with Student's *t* test. \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant. **(K)** Expression of dTBC1D7 in IPC neurons reduced membrane localization of GPH in *dTBC1D7^KO^* flies. "Control" refers to *Ilp2-Gal4/+* flies. Bar, 25 µm.](JCB_201706027_Fig4){#fig4}

Next, we sought to determine whether the ability of dTBC1D7 to control growth depends on its status as a component of the TSC. The same as TBC1D7 in mammals, dTBC1D7 interacted with TSC1 in vitro ([Fig. 5 A](#fig5){ref-type="fig"}), and expression of human TBC1D7 in IPC neurons (*Ilp2-Gal4*/*UAS-hTBC1D7*) rescued the systemic overgrowth of *dTBC1D7^KO^* mutants, including body weight and ommatidia and wing sizes. This indicates that TBC1D7 mediates conserved functions ([Fig. 5, B--D](#fig5){ref-type="fig"}). Work in mammals has shown that L114Q or L114R mutations in hTBC1D7 disrupt interactions between hTBC1D7 and TSC1 ([@bib22]; [@bib17]; [@bib46]). Bioinformatics analysis suggested that I125 within dTBC1D7 is L114 in hTBC1D7. Indeed, dTBC1D7^I125Q^ failed to interact with TSC1 in S2 cells ([Fig. 5 A](#fig5){ref-type="fig"}). Therefore, we expressed *dTBC1D7^I125Q^* via *Ilp2-Gal4* in the *dTBC1D7^KO^* mutant background and found that *dTBC1D7^I125Q^* rescued the overgrowth phenotype to the same extent as wild-type dTBC1D7 ([Fig. 5, E--G](#fig5){ref-type="fig"}). This suggests that the function of dTBC1D7 in IPC neurons is independent of the TSC. Because it is very difficult to directly measure levels of mTORC1 kinase activity in IPC neurons, we genetically manipulated mTORC1 kinase activity in IPC cells. The TSC negatively regulates activity of the Rheb GTPase, and overexpression of Rheb increases intercellular mTORC1 activity in *Drosophila* ([@bib47]; [@bib48]). Here, we found that, in contrast to induction of systemic overgrowth by knockdown of *dTBC1D7^KO^* in IPCs, overexpression of Rheb in IPC neurons (via *Ilp2-Gal4*) did not affect systemic growth ([Fig. 5, H and I](#fig5){ref-type="fig"}). These biochemical and genetic results provide strong evidence that TBC1D7 regulates systemic growth in IPC neurons independently of the TSC.

![***dTBC1D7* controlled systemic growth independent of TSC. (A)** dTBC1D7^I125Q^ presented loss of interaction with TSC1 in S2 cells. **(B--D)** Expression of human *TBC1D7* in IPC neurons (*Ilp2-Gal4*/*UAS-hTBC1D7*) rescued the systemic overgrowth phenotypes of *dTBC1D7* mutants, including body weight (B), ommatidia size (C), and relative wing area (D). **(E--G)** Expression of TBC1D7^I125Q^ in IPC neurons (*Ilp2\>dTBC1D7^I125Q^: Ilp2-Gal4/UAS-dTBC1D7^I125Q^*) rescued the overgrowth phenotypes of the *dTBC1D7^KO^* (*KO*: *dTBC1D7^KO^*) animals. Body weight (E), wing area (F), and ommatidia size (G) were quantified. **(H--I)** Knockdown *dTBC1D7* in IPC neurons increased body weight (H) and wing size (I), whereas overexpression of Rheb in the IPC neurons did not. The "control" refers to the *Ilp2-Gal4/+* flies. At least 20 flies of each genotype were quantified. Significant differences were determined with Student's *t* test. \*\*\*, P \< 0.001; ns, not significant. Error bars indicate SD.](JCB_201706027_Fig5){#fig5}

Numerous studies have reported that up-regulation of this highly conserved insulin signaling pathway results in decreased fitness and reduced lifespan ([@bib6]; [@bib3]). These speculations, together with our observation that IPC neurons of *dTBC1D7* mutants secrete more ILP2, motivated us to test whether manipulation of *dTBC1D7* expression in IPC neurons affects longevity and stress resistance. We first monitored fly lifespan under normal conditions and found that loss of TBC1D7 shortened lifespan in both females and males (males were used for further analysis; Fig. S3 A). Similarly, overexpression of ILP2 and knockdown of *dTBC1D7* in IPC neurons also shortened life span.

Growth and aging processes are also controlled by a variety of stresses in the environment ([@bib25]; [@bib7]; [@bib3]; [@bib34]). Thus, we next exposed *dTBC1D7* mutant flies to oxidative stress. This type of stress was induced by using 5 mM paraquat, which is toxic and causes mitochondrial dysfunction ([@bib25]; [@bib23]). The *dTBC1D7* mutant flies exhibited a greatly reduced life span in response to paraquat treatment compared with controls (Fig. S3 B). These results suggest that *dTBC1D7* is an important regulator of stress responses and life span in IPC neurons within the *Drosophila* central nervous system.

Aging is generally associated with a decline in mitochondrial function, and various studies have demonstrated that the aging process eventually disrupts muscle tissue homeostasis ([@bib8]). Here, we found that mitochondria from 30-d-old *dTBC1D7* mutants were vacuolated and had disrupted cristae when compared with wild-type flies of the same age (Fig. S3 C). Consistent with this mitochondrial degeneration, behavioral assays conducted with 30-d-old flies revealed that the climbing activities of *dTBC1D7* mutants were significantly reduced compared with wild-type flies (Fig. S3 D). These data represent subcellular and behavioral evidence that the disruption of TBC1D7 function results in outcomes associated with the aging process. This suggests that TBC1D7 regulates processes that integrate growth and aging.

In summary, we describe for the first time the physiological function of TBC1D7 in regulating ILP biogenesis and secretion, which in turn affects growth, stress response, and life span. Although biochemical studies have demonstrated that TBC1D7 physically associates with the TSC ([@bib46]; [@bib18]; [@bib43]), clinical manifestations of TBC1D7-related diseases \[namely, intellectual disabilities and megalocephaly with unknown mechanisms ([@bib10]; [@bib2])\] are very different from those associated with *TSC1* or *TSC2* mutations, which usually result in tumorigenesis through the constitutive activation of mTORC1 ([@bib15]; [@bib50]). In *Drosophila*, it has been reported that CG6182 is the homologue of mammalian TBC1D7 ([@bib26]; [@bib52]). After searching for TBC1D7 homologues in the fly genome, we found that CG6182 is the only homologue of human TBC1D7. Moreover, expression of human TBC1D7 can substitute for dTBC1D7 to control systemic growth. Using the *Drosophila* model system, we demonstrate that dTBC1D7 plays a critical role in regulating neuropeptides such as ILP2 in the specific IPC neurons and that dTBC1D7 performs this role independent of the TSC. In mammals, TBC1D7 has been shown to contribute to TSC1/TSC2 function ([@bib14]; [@bib46]). However, databases of protein expression patterns indicate that TSC1/2 and TBC1D7 are not always expressed together. TSC1 and TSC2 are expressed throughout the body, whereas TBC1D7 localizes to specific regions, such as the hippocampus in mammalian brains ([@bib37]). This suggests that TBC1D7 may play a conserved TSC1/2-independent role in neuron-related physiological processes in *Drosophila* and mammals. In fact, mammalian studies have shown that insulin/IGF signaling is essential for neurogenesis, learning, and sensory perception ([@bib25]; [@bib16]). Thus, our results have important implications for human health and help explain why mutations in human *TBC1D7* cause intellectual disabilities.

In mammals, multiple IGFs (including one insulin, two IGFs, three relaxins, and several ILPs) have been shown to function separately ([@bib16]), and in flies recent studies have strongly suggested that the transcription and release of individual ILPs from IPCs may be regulated independently by different triggers ([@bib21]; [@bib7]; [@bib1]). However, it has not yet been determined how ILP2, ILP3, and ILP5 are differentially regulated in IPCs. Here we demonstrated that dTBC1D7 functions in IPCs to selectively regulate the expression of ILP2. Therefore, dTBC1D7 is the first IPC cell-autonomous factor that has been shown to regulate the expression of a selective ILP. Thus, dTBC1D7 may represent a key mechanism by which nutrient signaling is relayed to ultimately affect ILP2 expression and release. Although our work reveals that dTBC1D7 regulates ILP2 biosynthesis in vivo, the molecular mechanisms remain to be discovered.

Materials and methods {#s03}
=====================

Drosophila stocks {#s04}
-----------------

The following fly strains were used in this study: *w^1118^*, *UAS-tsc1*, *UAS-tsc2*, and *UAS-Rheb* flies, which have been described previously ([@bib53]). The *ilp2^1^* (BL30881), *Mhc-Gal4* (BL55133), *elav-Gal4* (BL25750), *da-Gal4* (BL55851), *MARCM82B* (BL44408), *tGPH* (BL8163), *Ilp2-Gal4* (BL37516), *ey-Gal4 UAS-FLP; FRT82B GMR-hid* (BL5253) and *hs-flp; UAS-dcr2; actin\>\>CD2\>\>Gal4 UAS-GFP* (BL4780), *GMR-Gal4* (BL8605) flies were obtained from the Bloomington Stock Center. The *nos-Cas9* (TH00787.N) flies and *dTBC1D7* (TH0439) *RNAi* flies were obtained from TsingHua Fly Center. The *dTBC1D7^KO^* and *dTBC1D7-mCherry* flies were generated by a Cas9/sgRNA system. The *UAS-dTBC1D7*, *UAS-dTBC1D7^I125Q^*, and *UAS-ilp2* flies were generated by site-specific transgenic technique.

Generation of knockout and knock-in flies {#s05}
-----------------------------------------

The *dTBC1D7^KO^* mutations were generated by the Cas9/sgRNA system ([@bib55]). Two recognition sequences of guiding RNA to the *dTBC1D7* locus were designed (sgRNA1: 5′-TGCTAGGGTGTTACCAGCGT-3′; sgRNA2: 5′-AAGATATGGGACAAAGTCTG-3′) and cloned into the *U6b-sgRNA-short* vector. The plasmids were injected into the embryos of *nos-Cas9* flies and screened by PCR to identify the *dTBC1D7^KO^* deletions with a pair of primers (5′-CAATCGATTCGCATACCCTAC-3′ and 5′-CGCCATAGAGGATGTGTTC-3′).

The *dTBC1D7-mcherry* knock-in flies were generated as shown in Fig. S2. In brief, sgDNA sequence was designed and cloned into the *U6b-sgRNA-short* vector. Two (∼1.5 kb) fragments of *dTBC1D7* genomic region (−1,500 to +30 and +30 to +1,550; +1 is the transcription initiation site) were subcloned into a *PDM19-mCherry* vector so that they were separated by the *3XP3-mCherry* marker. The two plasmids were co-injected into the embryos of *nos-Cas9* flies, and the subsequent mCherry-positive progenies were screened and crossed with *hs-Cre;CDX/TM3* flies to delete the 3XP3 promoter region. The *dTBC1D7-mCherry* flies were confirmed by PCR by using the following primers: 5′-GCATAATTTATCGCGGGCCTGCATG-3′ and 5′-CATGGTCTTCTTCTGCATTACG-3′.

Both *dTBC1D7^KO^* and *dTBC1D7-mcherry* flies were backcrossed with wild-type flies (*w^1118^*) for six generations before preforming experiments. Each time, female progeny carrying the *dTBC1D7^KO^* or *dTBC1D7-mcherry* chromosome were selected for the next cross.

Starvation treatment {#s06}
--------------------

For monitoring fly development, eggs were collected every 4 h, as described ([@bib21]). Larvae were raised at a standard density of ≤40/tube in standard cornmeal/sugar medium. We used 1% yeast in 1% nonnutritive agar without any additives as starvation medium. For starvation, third instar larvae (90 h after egg deposition) were selected, washed in water, and shifted to starvation medium for 5 h. Then, fat body tissues were dissected and homogenized in 10 mM Tris-HCl lysis buffer (pH 7.4, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 25 mM NaF, and 1 mM Na~3~VO~4~ with 1× proteinase inhibitor cocktail \[Sigma-Aldrich\]).

Generation of transgenic flies {#s07}
------------------------------

The *dTBC1D7 and ilp2* cDNA sequences were amplified from LD17019 and GH11579 cDNA clones obtained from DGRC (*Drosophila* Genomics Resource Center) and subcloned into the *pUAST-attB* vector between the EcoRI and XbaI sites. The *UAS-dTBC1D7*, *UAS-dTBC1D7^I125Q^*, and *UAS-ilp2* constructs were injected into *M (vas-int.Dm)ZH-2A;M(3xP3-RFP.attP) ZH-86Fb* embryos, and transformants were identified on the basis of eye color.

Cell culture, dsRNA synthesis, and immunoprecipitation {#s08}
------------------------------------------------------

S2 cells were grown in Schneider's *Drosophila* medium (Sigma-Aldrich) with 10% fetal bovine serum (Gibco BRL), and transfected with Vigofect reagent (Vigorous Biotechnology). dsRNA was synthesized in vitro and transfected as reported ([@bib33]). Cells were lysed with 10 mM Tris-HCl lysis buffer (pH 7.4, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 25 mM NaF, and 1 mM Na~3~VO~4~ with 1× proteinase inhibitor cocktail \[Sigma-Aldrich\]). Immunoprecipitations were performed with HA beads (Sigma-Aldrich), Flag beads (Sigma-Aldrich), and GFP beads (Chromotek).

Measurement of body weight, cell number, and cell size {#s09}
------------------------------------------------------

All flies' growth and crosses were performed according to standard procedures at 25°C under a 12-h light/dark cycle. Each vial contained \<50 progenies to avoid overcrowding. After eclosion, males and females were separated, and 3-d-old flies were weighed with an electronic balance (AL104; Mettler Toledo). Wing size and cell number were measured as reported ([@bib5]). In brief, wings were dissected and mounted in Turpentine oil (Sigma-Aldrich). Pictures were acquired by using an Eclipse Ni-E Microscope (Nikon) at room temperature with a Plan Fluor 4× NA = 0.13 (for measurement of wing size) and Plan Fluor Plan Apo 20× NA = 0.75 (for measurement of cell number) objective lens and a DS-U3 camera (Nikon). The number of wing hairs on the dorsal wing surface in 10,000-µm^2^ was measured by ImageJ and defined as cell density (d). Each wing acquired at least three areas for calculation of the mean density (d~m~), and the whole wing area (S) excluding the alula and the costal cells was measured. The approximate number of cells in the whole wing area was calculated as total cell number = d~m~ × S. We counted the number of ommatidia in the middle rows (rows 14--18) of compound eyes from scanning electron microscopy pictures (200×) as an estimation of the total number of ommatidia.

Oxidative stress resistance and life span analysis {#s10}
--------------------------------------------------

For oxidative stress assays, 3-d-old male flies were transferred to food containing 5 mM paraquat and 5% sucrose solution (25--30 flies/vial). The flies were transferred to new food every 24 h, and fly survival was monitored.

Analysis of life span was performed according to methods previously described ([@bib7]; [@bib23]; [@bib3]). More than 200 male flies were separated and raised in a 25°C, 65% humidity-controlled incubator (25--30 flies/vial) under a 12-h light/dark cycle. Dead flies were counted and removed every 2 d, and the remaining flies were flipped into new vials.

Immunofluorescence staining {#s11}
---------------------------

Immunofluorescence assays were performed as previously described ([@bib12]; [@bib32]). In brief, tissues were dissected and fixed in PBS with 4% paraformaldehyde (Sigma-Aldrich) for 2 h at 4°C and then incubated with primary antibodies including rabbit anti--ILP2 antibody (1:200; a gift from H. Stocker, ETH Zurich, Zurich, Switzerland), rabbit anti--GFP antibody (1:200; Invitrogen), mouse anti-GFP (DSHB), or mouse anti--RFP antibody (1:200; Allele) overnight at 4°C. Finally, samples were stained with Alexa Fluor 488--conjugated, Alexa Fluor 568--conjugated, Alexa Fluor 647--conjugated secondary antibodies (1:500; Invitrogen), 20 nM phalloidin (Invitrogen), and DAPI (Invitrogen) for 2 h at room temperature. Fluorescence images were acquired at room temperature with an A1 confocal laser scanning microscope (Nikon) by using a 40× air objective (Plan Fluor NA 1.30; Nikon) and an A1^+^ camera (Nikon).

Hemolymph extraction and glucose determination {#s12}
----------------------------------------------

We obtained the hemolymph by bleeding 100 larvae 110 h after egg deposition as described previously ([@bib12]; [@bib32]). After centrifugation at 500 *g* for 30 min at 4°C, supernatants were transferred to a new tube, followed by additional centrifugation at 16,000 *g* for 20 min at 4°C. The supernatant was collected as hemolymph. Glucose levels were determined by a glucose assay kit according to its user manual (GAGO-20; Sigma-Aldrich).

Western blot analysis {#s13}
---------------------

Western blot analysis was performed as described previously ([@bib27]). The rabbit anti-pS6K (Thr398), rabbit anti-pAKT (S505), rabbit anti--AKT antibody (1:1,000; Cell Signaling), mouse anti-actin (1:10,000; Santa Cruz Biotechnology), and rat anti--ILP2 antibody (1:8,000; a gift from P. Léopold, Institute of Biology Valrose, Parc Valrose, France) were used as primary antibodies. The blots were subsequently probed with IRDye 800 IgG, IRDye 680 IgG (LI-COR Biosciences), or peroxidase conjugate IgG (Invitrogen). Signals were detected with either an Odyssey infrared imaging system (LI-COR Biosciences) or ECL reagents (Thermo).

qPCR {#s14}
----

Total RNA was prepared with Trizol reagent (Invitrogen) from larval fat body, larval brain, larval gut, adult head, or adult thorax. Total cDNA was synthesized with RT master mix (RR036A-1; Takara). An iQ SYBR green supermix was used for real-time PCR (Bio-Rad). The following primers were used for this study: *ilp1*: forward, 5′-CCCCGGAAACCACAAACTCT-3′; reverse, 5′-TAAAGCCATGGGGACACACC-3′; *ilp2*: forward, 5′-GGTGTGTCCCCATGGCTTTA-3′; reverse, 5′-TGCTGCTATCATCCTGCACC-3′; *ilp3*: forward, 5′-GTGTATGGCTTCAACGCAATG-3′; reverse, 5′-CAGCAGGGAACGGTCTTCG-3′; *ilp4*: forward, 5′-TGGATTTACACGCCGTGTCA-3′; reverse, 5′-GGTCTCGCACTCTAGCATCC-3′; *ilp5*: forward, 5′-TGCCTGTCCCAATGGATTCAA-3′; reverse, 5′-GCCAAGTGGTCCTCATAATCG-3′; *ilp6*: forward, 5′-GTCCAAAGTCCTGCTAGTCCT-3′; reverse, 5′-TCTGTTCGTATTCCGTGGGTG-3′; *ilp7*: forward, 5′-CCTGGCTGCACGTGAACTAT-3′; reverse, 5′-TGGATGGACAATACTCGGCG-3′; *rpl32*: forward, 5′-GCCGCTTCAAGGGACAGTATCTG-3′; reverse, 5′-AAACGCGGTTCTGCATGAG-3′; *dTBC1D7*: forward, 5′-AACTACACAGTGCCGAACAAC-3′; reverse, 5′-CGTACATTTCGCGTCTTTGGTC-3′; *s6k*: forward, 5′-ACTGGGCGCTCTCATGTTTG-3′; reverse, 5′-TTGGCTTTCAGAATGGTCT-3′.

Climbing assay {#s15}
--------------

Climbing assays were performed as described ([@bib54]). In brief, groups of twenty 30-d-old flies were assayed. Flies were transferred into a 100-ml dose tank containing a wet filter paper for 1 h. Then flies were shaken to the bottom of tanks, and the time taken for a median number of flies to reach a height of 15 cm was recorded. For each genotype, 100 flies were tested, and the average climbing rate (R = 15/time) was calculated.

Transmission electron microscopy (TEM) and scanning electron microscopy {#s16}
-----------------------------------------------------------------------

TEM and scanning electron microscopy were performed with standard methods as described previously ([@bib53]). For TEM, dissected muscles were prefixed with 4% paraformaldehyde and 2.5% at 4°C followed by incubation in 1% osmium tetroxide for 1 h at 4°C. Then samples were dehydrated in a series of ethanol (10, 25, 50, 75, and 100% ethanol) and embedded in LR White resin (Polysciences, Inc.). Thin sections were prepared and examined by using a JEM-1400 transmission electron microscope (JEOL) at room temperature. The images were acquired by using a Gatan camera (model 794; Gatan, Inc.).

For scanning electron microscopy, fly heads were dehydrated with a series of ethanol and immersed in hexamethyldisilazane at room temperature. Samples were mounted and coated with gold/palladium after solvent was evaporated off. The samples were examined with a JSM-5800 microscope (JEOL). The area of 10 ommatidia in high-magnification (1,000×) scanning electron microscopy pictures was measured with ImageJ, and the mean ommatidium size was calculated.

Image processing and statistical analysis {#s17}
-----------------------------------------

All the original fluorescent images were exported in tiff format by NIS-Elements viewer 4.0. TEM and scanning electron microscopy images were acquired and saved in tiff format embedded with a scale bar by Digital Micrograph software (Gatan, Inc.). Quantifying the area of ommatidia, wings and mosaic clones was achieved with ImageJ software.

The SD was used as y axis error bars for quantification of the data. Datasets were analyzed by Student's unpaired *t* test, and data were considered statistically different at P \< 0.05. Life span and stress assays were analyzed with SPSS software, and the log-rank method was used to calculate p-values.

Online supplemental material {#s18}
----------------------------

Fig. S1 shows that dTBC1D7 is fly homologue of TBC1D7 and how the *dTBC1D7* knockout flies were generated. Fig. S2 illustrates the schemes for generation the *dTBC1D7-mCherry* knock-in flies. Fig. S3 shows that dTBC1D7 regulates longevity and protects against oxidative stress.
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